BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16954464)

  • 1. Assessing breast cancer risk: evolution of the Gail Model.
    Bondy ML; Newman LA
    J Natl Cancer Inst; 2006 Sep; 98(17):1172-3. PubMed ID: 16954464
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.
    Palomares MR; Machia JR; Lehman CD; Daling JR; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1324-30. PubMed ID: 16835331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective breast cancer risk prediction model for women undergoing screening mammography.
    Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
    J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
    Chen J; Pee D; Ayyagari R; Graubard B; Schairer C; Byrne C; Benichou J; Gail MH
    J Natl Cancer Inst; 2006 Sep; 98(17):1215-26. PubMed ID: 16954474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the Gail model: lobular involution may help refine breast cancer risk assessment.
    Rowan K
    J Natl Cancer Inst; 2009 Feb; 101(3):134-5. PubMed ID: 19176450
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Anderson BO
    J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
    [No Abstract]   [Full Text] [Related]  

  • 9. Women's health. Mammography: why is there a debate?
    Harv Health Lett; 2002 Jun; 27(8):4-5. PubMed ID: 12079814
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Efficacy of breast cancer screening in the community according to risk level.
    Duffy SW; Smith RA; Tabar L
    J Natl Cancer Inst; 2005 Nov; 97(22):1703; author reply 1703-4. PubMed ID: 16288125
    [No Abstract]   [Full Text] [Related]  

  • 11. Should routine screening by mammography be replaced by a more selective service of risk assessment/risk management?
    Baum M
    Womens Health (Lond); 2010 Jan; 6(1):71-6. PubMed ID: 20088731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and treatment of ductal carcinoma in situ of the breast.
    Kopans DB
    JAMA; 1996 Sep; 276(11):869; author reply 870-71. PubMed ID: 8782627
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammography in younger women: the dilemma of diminishing returns.
    Calonge N
    J Natl Cancer Inst; 2010 May; 102(10):668-9. PubMed ID: 20439837
    [No Abstract]   [Full Text] [Related]  

  • 14. Just how good can we get?
    Reitherman RW
    Radiol Technol; 1994; 65(5):307-8. PubMed ID: 8058913
    [No Abstract]   [Full Text] [Related]  

  • 15. A decline in breast-cancer incidence.
    Cady B; Chung MA; Michaelson JS
    N Engl J Med; 2007 Aug; 357(5):511; author reply 513. PubMed ID: 17674459
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral breast cancer: early detection with mammography.
    Roubidoux MA; Helvie MA; Lai NE; Paramagul C
    Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing breast cancer by utilizing Gail model.
    Seyednoori T; Pakseresht S; Roushan Z
    Women Health; 2012; 52(4):391-402. PubMed ID: 22591234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Efficacy of breast cancer screening in the community according to risk level.
    Paci E; Zappa M
    J Natl Cancer Inst; 2005 Nov; 97(22):1704; author reply 1704-5. PubMed ID: 16288126
    [No Abstract]   [Full Text] [Related]  

  • 19. [Breast carcinoma: successful early diagnosis, increased mortality].
    Paterok EM; Siebzehnrübl E; Schulz-Wendtland R; Koch T
    Rontgenpraxis; 1995 May; 48(5):125-31. PubMed ID: 7792664
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
    Weaver DL; Vacek PM; Skelly JM; Geller BM
    Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.